Brief: Endra Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement
22/11/2024 13:57
Nov 22 (Reuters) - Nasdaq Inc NDAQ.O :
* ENDRA LIFE SCIENCES REGAINS COMPLIANCE WITH NASDAQ MINIMUM
BID
PRICE REQUIREMENT
Source text: ID:nBw86V0z8a
Further company coverage: NDAQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences